Screener / SEC EDGAR /CIK 0002046386 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Medical Instruments

Medline Inc. MDLN

Compare with peers Embed
What it said it expected, against what it reported

No target with a reported result yet

Releases of the last 3 years

The numbers MDLN said it expected, in its earnings releases, next to what it then reported for the same period.

Target by target

Each target, with the sentence it came from · release and 10-Q or 10-K

The last range givenReported, abovewithin or keptbelow or missed
TargetWhat the company saidReportedResult
EBITDA (company-defined)
Fiscal 2026
Given $3.50B to $3.60B release Feb 25, 2026
Lowered $3.30B to $3.40B release Nov 4, 2026
– No standard number
The company's words
For full year 2026, the Company expects Organic Sales 4 growth of 8% to 9% and Adjusted EBITDA 4 of $3.5 to $3.6 billion. release Feb 25, 2026
The Company is raising its full year 2026 outlook for Organic Sales 2 growth to 10.0% to 10.5%, compared to its previous outlook of 9.0% to 10.0%, and reaffirming its Adjusted EBITDA 2 outlook of $3.3 billion to $3.4 billion. release Nov 4, 2026

Targets are read from the sentences of the EX-99 exhibits of 8-K item 2.02 filings (4 releases since 2026-02-25), without AI; in outlook tables only the first column is read. The result compares the reported number with the last range given before the period was reported. Results come from SEC's XBRL company facts, as first reported. A company's target can use its own definition (META's capital expenditures include finance lease payments, for example), so read the quote.

Sources

The outlook sentences of each earnings release (8-K item 2.02, exhibit 99), read without AI; results from SEC's XBRL company facts, as first reported.

Also

Earnings releases: each release in full.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/MDLN/export.csv") into a cell.

Next:Archive
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.